{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:45:45Z","timestamp":1783647945505,"version":"3.55.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472861"],"award-info":[{"award-number":["81472861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871136"],"award-info":[{"award-number":["81871136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501231"],"award-info":[{"award-number":["81501231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771638"],"award-info":[{"award-number":["81771638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.543246","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T15:18:08Z","timestamp":1600442288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine"],"prefix":"10.3389","volume":"11","author":[{"given":"Shu-Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Liang","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American thyroid association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid."},{"key":"B3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American thyroid association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid."},{"key":"B4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","article-title":"Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective","volume":"259","author":"Brauckhoff","year":"2014","journal-title":"Ann Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/hmg\/ddw057","article-title":"Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression","volume":"25","author":"Smith","year":"2016","journal-title":"Hum Mol Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/humu.23378","article-title":"Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer","volume":"39","author":"Sponziello","year":"2018","journal-title":"Hum Mutat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1002\/humu.1380110143","article-title":"Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A","author":"Hoppner","year":"1998","journal-title":"Hum Mutat."},{"key":"B9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-2006-924071","article-title":"Double germline mutations in the RET proto-oncogene in MEN 2A and MEN 2B kindreds","volume":"114","author":"Dvorakova","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6061\/clinics\/2012(Sup01)13","article-title":"Genotype-phenotype correlation in multiple endocrine neoplasia type 2","volume":"67","author":"Raue","year":"2012","journal-title":"Clinics."},{"key":"B11","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/ERC-17-0202","article-title":"Advances in risk-oriented surgery for multiple endocrine neoplasia type 2","volume":"25","author":"Machens","year":"2018","journal-title":"Endocr Relat Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","article-title":"Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2011","journal-title":"Hum Mutat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/thy.2009.0021","article-title":"Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis","volume":"19","author":"Rothberg","year":"2009","journal-title":"Thyroid."},{"key":"B14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10689-016-9892-6","article-title":"MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics","volume":"15","author":"Scapineli","year":"2016","journal-title":"Fam Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1530\/EC-18-0220","article-title":"The RET C611Y mutation causes MEN 2A and associated cutaneous","volume":"7","author":"Qi","year":"2018","journal-title":"Endocr Connect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/07357907.2018.1430813","article-title":"The clinical spectrum of multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis in ethnic han Chinese","volume":"36","author":"Qi","year":"2018","journal-title":"Cancer Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1399-0004.1997.tb02425.x","article-title":"A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis","volume":"51","author":"Seri","year":"1997","journal-title":"Clin Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/1523-1747.ep12329651","article-title":"RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia","volume":"107","author":"Hofstra","year":"1996","journal-title":"J Invest Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-2002-26712","article-title":"Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A","volume":"34","author":"Vieira","year":"2002","journal-title":"Horm Metab Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1046\/j.1365-2265.2003.01782.x","article-title":"Frequent association between MEN 2A and cutaneous lichen amyloidosis","volume":"59","author":"Verga","year":"2003","journal-title":"Clin Endocrinol."},{"key":"B21","first-page":"779","article-title":"Rare manifestation of multiple endocrine neoplasia type 2A & cutaneous lichen amyloidosis in a family with RET gene mutation","volume":"139","author":"Birla","year":"2014","journal-title":"Indian J Med Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4158\/EP.8.1.19","article-title":"Early onset of medullary thyroid carcinoma in a kindred with multiple endocrine neoplasia type iia associated with cutaneous lichen amyloidosis","volume":"8","author":"Lemos","year":"2002","journal-title":"Endocr Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF03347719","article-title":"Identification of the Cys634\u2013>Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis","volume":"17","author":"Ceccherini","year":"1994","journal-title":"J Endocrinol Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF03348840","article-title":"Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family","volume":"16","author":"Pacini","year":"1993","journal-title":"J Endocrinol Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1530\/eje.0.1390410","article-title":"Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma","volume":"139","author":"Karga","year":"1998","journal-title":"Eur J Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2265.1991.tb00322.x","article-title":"Primary localized cutaneous amyloidosis and familial medullary thyroid carcinoma","volume":"34","author":"Ferrer","year":"1991","journal-title":"Clin Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/BF03347557","article-title":"Multiple endocrine neoplasia type 2A\/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma","volume":"28","author":"Gullu","year":"2005","journal-title":"J Endocrinol Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0039-6060(02)21685-2","article-title":"Cutaneous lichen amyloidosis in a family with familial medullary thyroid cancer","volume":"135","author":"Abdullah","year":"2004","journal-title":"Surgery."},{"key":"B29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00383-014-3538-2","article-title":"The association between Hirschsprung's disease and multiple endocrine neoplasia type 2a: a systematic review","volume":"30","author":"Coyle","year":"2014","journal-title":"Pediatr Surg Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1002420","DOI":"10.1371\/journal.pgen.1002420","article-title":"Positive selection for new disease mutations in the human germline: evidence from the heritable cancer syndrome multiple endocrine neoplasia type 2B","volume":"8","author":"Choi","year":"2012","journal-title":"PLoS Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1210\/jc.2016-3640","article-title":"Risk profile of the RET A883F germline mutation: an international collaborative study","volume":"102","author":"Mathiesen","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-016-0873-1","article-title":"Management of hereditary medullary thyroid carcinoma","volume":"53","author":"Pappa","year":"2016","journal-title":"Endocrine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1089\/thy.2018.0385","article-title":"RET S409Y germline mutation and associated medullary thyroid carcinoma","volume":"29","author":"Qi","year":"2019","journal-title":"Thyroid."},{"key":"B34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1530\/ERC-16-0141","article-title":"M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds","volume":"23","author":"Martins-Costa","year":"2016","journal-title":"Endocr Relat Cancer."},{"key":"B35","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/ERC-17-0209","article-title":"A comprehensive review on MEN2B","volume":"25","author":"Castinetti","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.fertnstert.2003.09.082","article-title":"Over a decade of experience with preimplantation genetic diagnosis: a multicenter report","volume":"82","author":"Verlinsky","year":"2004","journal-title":"Fertil Steril."},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/thy.2017.0200","article-title":"Preimplantation genetic diagnosis of multiple endocrine neoplasia type 2A using informative markers identified by targeted sequencing","volume":"28","author":"Chen","year":"2018","journal-title":"Thyroid."},{"key":"B39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.fertnstert.2013.02.043","article-title":"Use of preimplantation genetic diagnosis for serious adult onset conditions: a committee opinion","volume":"100","year":"2013","journal-title":"Fertil Steril"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e51024","DOI":"10.1371\/journal.pone.0051024","article-title":"Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum","volume":"7","author":"Macher","year":"2012","journal-title":"PLoS ONE."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0153258","DOI":"10.1371\/journal.pone.0153258","article-title":"Fetal genotyping in maternal blood by digital PCR: towards NIPD of monogenic disorders independently of parental origin","volume":"11","author":"Perlado","year":"2016","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41591-018-0334-x","article-title":"Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA","volume":"25","author":"Zhang","year":"2019","journal-title":"Nat Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/gim.2014.51","article-title":"Noninvasive prenatal testing for autosomal recessive conditions by maternal plasma sequencing in a case of congenital deafness","volume":"16","author":"Meng","year":"2014","journal-title":"Genet Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00000658-197808000-00002","article-title":"Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland","volume":"188","author":"Wells","year":"1978","journal-title":"Ann Surg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-2265.1996.505292.x","article-title":"The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families","volume":"44","author":"Marsh","year":"1996","journal-title":"Clin Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/thy.2012.0236","article-title":"Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma","volume":"23","author":"Frank-Raue","year":"2013","journal-title":"Thyroid."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1515\/cclm-2018-1186","article-title":"Calcitonin measurement in pediatrics: reference ranges are gender-dependent, validation in medullary thyroid cancer and thyroid diseases","volume":"57","author":"Eckelt","year":"2019","journal-title":"Clin Chem Lab Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.276.19.1575","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 international RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA."},{"key":"B50","doi-asserted-by":"publisher","first-page":"T189","DOI":"10.1530\/ERC-18-0141","article-title":"65 years of the double helix: exploiting insights on the RET receptor for personalized cancer medicine","volume":"25","author":"Mulligan","year":"2018","journal-title":"Endocr Relat Cancer."},{"key":"B51","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000346174","article-title":"2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","journal-title":"Eur Thyroid J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e20353","DOI":"10.1371\/journal.pone.0020353","article-title":"RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A\/familial medullary thyroid carcinoma family","volume":"6","author":"Qi","year":"2011","journal-title":"PLoS ONE."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1089\/thy.2012-0134","article-title":"RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China","volume":"22","author":"Qi","year":"2012","journal-title":"Thyroid."},{"key":"B54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10689-011-9487-1","article-title":"Case report: a p","volume":"11","author":"Qi","year":"2012","journal-title":"Fam Cancer."},{"key":"B55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12038-014-9428-x","article-title":"The rare intracellular RET mutation p","volume":"39","author":"Qi","year":"2014","journal-title":"J Biosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ejso.2013.06.015","article-title":"Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China","volume":"39","author":"Qi","year":"2013","journal-title":"Eur J Surg Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13053-015-0026-1","article-title":"Molecular diagnosis and comprehensive treatment of multiple endocrine neoplasia type 2 in Southeastern Chinese","volume":"13","author":"Zhao","year":"2015","journal-title":"Hered Cancer Clin Pract."},{"key":"B58","doi-asserted-by":"publisher","first-page":"33993","DOI":"10.18632\/oncotarget.4992","article-title":"RET mutation p","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget."},{"key":"B59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12038-017-9686-5","article-title":"Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing","volume":"42","author":"Du","year":"2017","journal-title":"J Biosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMra1711801","article-title":"Next-generation sequencing to diagnose suspected genetic disorders","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","article-title":"Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2","volume":"340","author":"Eisenhofer","year":"1999","journal-title":"N Engl J Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1210\/jc.2004-1836","article-title":"Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level","volume":"90","author":"Machens","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1200\/JCO.2006.06.8171","article-title":"Pretargeted anti-carcinoembryonic-antigen radioimmunotherapy for medullary thyroid carcinoma","volume":"24","author":"Machens","year":"2006","journal-title":"J Clin Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1515\/cclm-2016-0572","article-title":"Utility of proGRP as a tumor marker in the medullary thyroid carcinoma","volume":"55","author":"Parra-Robert","year":"2017","journal-title":"Clin Chem Lab Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1089\/105072501753271752","article-title":"Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma","volume":"11","author":"Ide","year":"2001","journal-title":"Thyroid."},{"key":"B66","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","journal-title":"Clin Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2016.10.012","article-title":"Preoperative levels of catecholamines and metanephrines and intraoperative hemodynamics of patients undergoing pheochromocytoma and paraganglioma resection","volume":"100","author":"Weingarten","year":"2017","journal-title":"Urology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/COC.0b013e3182a78fec","article-title":"Early. prophylactic thyroidectomy in hereditary medullary thyroid carcinoma: a 26-year monoinstitutional experience","volume":"38","author":"Pelizzo","year":"2015","journal-title":"Am J Clin Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","article-title":"Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years","volume":"161","author":"Randle","year":"2017","journal-title":"Surgery"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/bjs.10856","article-title":"Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2","volume":"105","author":"Prete","year":"2018","journal-title":"Br J Surg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2019-00516","article-title":"long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center","volume":"104","author":"Raue","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B72","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3322\/caac.21195","article-title":"New developments in the diagnosis and treatment of thyroid cancer","volume":"63","author":"Schneider","year":"2013","journal-title":"CA Cancer J Clin."},{"key":"B73","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bjs.9384","article-title":"Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia","volume":"101","author":"Edafe","year":"2014","journal-title":"Br J Surg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jpedsurg.2019.06.027","article-title":"Children are at a high risk of hypocalcaemia and hypoparathyroidism after total thyroidectomy","volume":"55","author":"de Jong","year":"2019","journal-title":"J Pediatr Surg"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1097\/MD.0000000000001108","article-title":"Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2: retrospective cohort analysis","volume":"94","author":"Kluijfhout","year":"2015","journal-title":"Medicine."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1002\/bjs.10746","article-title":"Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations","volume":"105","author":"Machens","year":"2018","journal-title":"Br J Surg."},{"key":"B77","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.surg.2016.03.007","article-title":"Impact of central node dissection on postoperative morbidity in pediatric patients with suspected or proven thyroid cancer","volume":"160","author":"Machens","year":"2016","journal-title":"Surgery."},{"key":"B78","doi-asserted-by":"publisher","first-page":"109673","DOI":"10.1016\/j.ijporl.2019.109673","article-title":"Risk factors of post-surgery complications in children with thyroid cancer","volume":"127","author":"Babala","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e191752","DOI":"10.1001\/jamaoto.2019.1752","article-title":"Association between annual surgeon total thyroidectomy volume and transient and permanent complications","volume":"2019","author":"Meltzer","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B80","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1210\/jc.2005-0044","article-title":"Campion L. Kraeber-Bodere F, Chatal JF, G.T.E.S. Group. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma","volume":"90","author":"Barbet","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"B81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00259-019-04458-6","article-title":"EANM practice guideline for PET\/CT imaging in medullary thyroid carcinoma","volume":"47","author":"Giovanella","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.6004\/jnccn.2019.0044","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: colorectal version 2.2019","volume":"17","author":"Gupta","year":"2019","journal-title":"J Natl Compr Canc Netw."},{"key":"B83","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1158\/2159-8290.CD-18-0338","article-title":"Precision targeted therapy with BLU-667 for RET-driven cancers","volume":"8","author":"Subbiah","year":"2018","journal-title":"Cancer Discov."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/annonc\/mdy137","article-title":"Selective RET kinase inhibition for patients with RET-altered cancers","volume":"29","author":"Subbiah","year":"2018","journal-title":"Ann Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40265-020-01343-7","article-title":"Selpercatinib: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1200\/JCO.19.02551","article-title":"State-of-the-art strategies for targeting RET-dependent cancers","volume":"38","author":"Subbiah","year":"2020","journal-title":"J Clin Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-16-0484","volume":"22","author":"Raue","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00268-007-9402-y","article-title":"Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy","volume":"32","author":"Brauckhoff","year":"2008","journal-title":"World J Surg."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/SLA.0b013e318237480c","article-title":"Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy","volume":"254","author":"Scholten","year":"2011","journal-title":"Ann Surg."},{"key":"B90","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1530\/endoabs.37.S12.3","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study","volume":"15","author":"Castinetti","year":"2014","journal-title":"Lancet Oncol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e198898","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B92","doi-asserted-by":"publisher","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"Thosani","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"B93","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1530\/EJE-16-0920","article-title":"Endocrinology in pregnancy: pheochromocytoma in pregnancy: case series and review of literature","volume":"177","author":"van der Weerd","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/imj.12118","article-title":"Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy","volume":"43","author":"Song","year":"2013","journal-title":"Intern Med J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/01.sla.0000124448.49794.74","article-title":"Progress in the operative management of sporadic primary hyperparathyroidism over 34 years","volume":"239","author":"Irvin","year":"2004","journal-title":"Ann Surg."},{"key":"B96","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/BF03350044","article-title":"Pre- and peroperative diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia type 2a","volume":"12","author":"Spapen","year":"1989","journal-title":"J Endocrinol Invest."},{"key":"B97","first-page":"53","article-title":"[Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene]","volume":"24","author":"Spinelli","year":"2002","journal-title":"Pediatr Med Chir."},{"key":"B98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0165-4608(02)00663-5","article-title":"Multiple endocrine neoplasia type 2A: an unusual clinical presentation and association with renal dysplasia","volume":"141","author":"McIntyre","year":"2003","journal-title":"Cancer Genet Cytogenet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13256-017-1364-6","article-title":"Bilateral pheochromocytoma with ganglioneuroma component associated with multiple neuroendocrine neoplasia type 2A: a case report","volume":"11","author":"Efared","year":"2017","journal-title":"J Med Case Rep."},{"key":"B100","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1089\/thy.2016.0148","article-title":"Assessment of depression, anxiety. quality of life, and coping in long-standing multiple endocrine neoplasia type 2 patients","volume":"27","author":"Rodrigues","year":"2017","journal-title":"Thyroid."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1210\/js.2018-00371","article-title":"Quality of life and coping in multiple endocrine neoplasia type 2","volume":"3","author":"Correa","year":"2019","journal-title":"J Endocr Soc."},{"key":"B102","doi-asserted-by":"publisher","first-page":"T69","DOI":"10.1530\/ERC-17-0335","article-title":"Patient quality of life and prognosis in multiple endocrine neoplasia type 2","volume":"25","author":"Grey","year":"2018","journal-title":"Endocr Relat Cancer."},{"key":"B103","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.surg.2018.04.036","article-title":"Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations","volume":"164","author":"Mongelli","year":"2018","journal-title":"Surgery."},{"key":"B104","first-page":"141","article-title":"Psychosocial consequences of DNA analysis for MEN type 2","volume":"10","author":"Grosfeld","year":"1996","journal-title":"Oncology."},{"key":"B105","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1530\/ERC-17-0488","article-title":"The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2","volume":"25","author":"Moodley","year":"2018","journal-title":"Endocr Relat Cancer."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.543246\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T15:18:11Z","timestamp":1600442291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.543246\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":105,"alternative-id":["10.3389\/fendo.2020.543246"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.543246","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"article-number":"543246"}}